SCHEMBL15550491

SCHEMBL15550491

CCOC(=O)COc1ccccc1-n1ccnc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 5/20 0.51
USP2 O75604 1/20 0.47
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
MITF O75030 1/20 0.46
KMT2A Q03164 1/20 0.46
ABCB1 P08183 1/20 0.44
IDO1 P14902 1/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
PTPN1 P18031 1/20 0.44
S1PR4 O95977 1/20 0.44
LMNA P02545 1/20 0.44
ITGA4 P13612 1/20 0.44
HPGD P15428 1/20 0.44
S1PR1 P21453 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8540999 0.85 TBXAS1 (0.51) TBXAS1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL15551773 0.84 USP2 (0.53) USP2ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL1882925 0.82 IDO1 (0.51) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL10948212 0.78 TBXAS1 (0.72) TBXAS1USP2ALDH1A1
SCHEMBL1979034 0.78 CYP4F2 (0.53) TBXAS1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL27538174 0.78 ALDH1A1 (0.49) TBXAS1ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL2010417 0.76 USP2 (0.67) USP2ALDH1A1SMN1; SMN2KDM4EMAPT
SCHEMBL11233639 0.75 TBXAS1 (0.57) TBXAS1USP2ALDH1A1
SCHEMBL5511363 0.74 IDO1 (0.53) ALDH1A1SMN1; SMN2KDM4EMAPTMEN1
SCHEMBL16198144 0.74 PORCN (0.69) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014016789-A1 PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE DERIVATIVES AS PDE9 INHIBITORS CELON PHARMA S.A. (PL) 2014-01-30 WO disclosed